IHL’s Gameday preferred supplier for SANFL
Impression Healthcare’s (ASX: IHL) wholly-owned subsidiary, Gameday International has entered into a partnership with the South Australian National Football League (SANFL) which will facilitate marketing access to players across the state, effectively increasing its total partnership customer marketing reach to more than 980,000 grassroots sporting club members.
IHL’s Gameday Mouthguards are its first product offering with additional products planned for market in the near term. Essentially, Gameday Mouthguards are a much less expensive option to the traditional high-end custom mouthguards, yet they offer the key feature of being able to be customised to fit the wearer’s mouth.
Boosts client base by more than 100,000
The SANFL agreement has boosted Gameday’s exclusive marketing client base by more than 100,000, and given it is the peak body for Australian Rules football in South Australia this should significantly boost the group’s profile.
Importantly, a licensing agreement has been negotiated which sees Gameday Mouthguards elevated to the position of preferred supplier of mouthguards to SANFL and affiliated leagues.
IHL is of course in the early stage of this relationship and any future expectations would be speculative at this stage. Please seek professional financial advice if considering this stock for your portfolio.
A strong endorsement by peak body
The licensing agreement not only suggests the likelihood of strong support for the group’s products, but it also represents an endorsement of the quality of the product by one of Australia’s leading sporting organisations.
It is worth noting that Gameday has existing partnerships with Southern Football Netball League, Basketball New South Wales, and Hockey WA, NSW and Victoria.
In terms of revenue recognition, management said that it expects sales income to commence at the start of the 2017 sporting season.
S3 Consortium Pty Ltd (CAR No.433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information only. Any advice is general advice only. Neither your personal objectives, financial situation nor needs have been taken into consideration. Accordingly you should consider how appropriate the advice (if any) is to those objectives, financial situation and needs, before acting on the advice.
Conflict of Interest Notice
S3 Consortium Pty Ltd does and seeks to do business with companies featured in its articles. As a result, investors should be aware that the Firm may have a conflict of interest that could affect the objectivity of this article. Investors should consider this article as only a single factor in making any investment decision. The publishers of this article also wish to disclose that they may hold this stock in their portfolios and that any decision to purchase this stock should be done so after the purchaser has made their own inquires as to the validity of any information in this article.
The information contained in this article is current at the finalised date. The information contained in this article is based on sources reasonably considered to be reliable by S3 Consortium Pty Ltd, and available in the public domain. No “insider information” is ever sourced, disclosed or used by S3 Consortium.